Antimicrobial ambiguine isonitriles from the cyanobacterium Fischerella ambigua
- PMID: 19371071
- PMCID: PMC2765494
- DOI: 10.1021/np800751j
Antimicrobial ambiguine isonitriles from the cyanobacterium Fischerella ambigua
Abstract
Five new antibacterial ambiguine K-O isonitriles (1-5) and eight previously described indole alkaloids were isolated from the cultured cyanobacterium Fischerella ambigua (UTEX 1903) by bioassay-guided fractionation. The planar structures of the new compounds were determined by spectroscopic analysis including MS and 1D and 2D NMR. X-ray crystallography was used to determine the absolute stereoconfiguration of ambiguine K isonitrile. The isolates were evaluated for their antibacterial activities against a set of bacterial targets, including Mycobacterium tuberculosis and Bacillus anthracis. Ambiguine K and M isonitriles showed the most potent activity against M. tuberculosis, with MIC values of 6.6 and 7.5 microM, respectively. Ambiguine A isonitrile showed the most potent activity against B. anthracis, with a MIC of 1.0 microM.
Figures
Similar articles
-
Hapalindole-related alkaloids from the cultured cyanobacterium Fischerella ambigua.Phytochemistry. 2010 Dec;71(17-18):2116-23. doi: 10.1016/j.phytochem.2010.09.004. Epub 2010 Oct 19. Phytochemistry. 2010. PMID: 20965528 Free PMC article.
-
Antimicrobial ambiguines from the cyanobacterium Fischerella sp. collected in Israel.J Nat Prod. 2007 Feb;70(2):196-201. doi: 10.1021/np060495r. J Nat Prod. 2007. PMID: 17315959
-
An antimicrobial guanidine-bearing sesterterpene from the cultured cyanobacterium Scytonema sp.J Nat Prod. 2009 Nov;72(11):2043-5. doi: 10.1021/np900288x. J Nat Prod. 2009. PMID: 19888742 Free PMC article.
-
Indole alkaloids from two cultured cyanobacteria, Westiellopsis sp. and Fischerella muscicola.Bioorg Med Chem. 2012 Sep 1;20(17):5290-5. doi: 10.1016/j.bmc.2012.06.030. Epub 2012 Jul 5. Bioorg Med Chem. 2012. PMID: 22863526 Free PMC article.
-
Antibacterial, antifungal and antimycobacterial compounds from cyanobacteria.Biomed Pharmacother. 2017 Jun;90:760-776. doi: 10.1016/j.biopha.2017.04.030. Epub 2017 Apr 15. Biomed Pharmacother. 2017. PMID: 28419973 Review.
Cited by
-
A Review of the Antimicrobial Properties of Cyanobacterial Natural Products.Molecules. 2023 Oct 17;28(20):7127. doi: 10.3390/molecules28207127. Molecules. 2023. PMID: 37894609 Free PMC article. Review.
-
Marine Bacterial Secondary Metabolites: A Treasure House for Structurally Unique and Effective Antimicrobial Compounds.Mar Drugs. 2021 Sep 23;19(10):530. doi: 10.3390/md19100530. Mar Drugs. 2021. PMID: 34677431 Free PMC article. Review.
-
Natural Products from Cyanobacteria: Focus on Beneficial Activities.Mar Drugs. 2019 May 30;17(6):320. doi: 10.3390/md17060320. Mar Drugs. 2019. PMID: 31151260 Free PMC article. Review.
-
Developing 3-(2-Isocyano-6-methylbenzyl)-1H-indole Derivatives to Enhance the Susceptibility of Serratia marcescens by Occluding Quorum Sensing.ACS Infect Dis. 2023 Dec 8;9(12):2607-2621. doi: 10.1021/acsinfecdis.3c00433. Epub 2023 Nov 16. ACS Infect Dis. 2023. PMID: 37971550 Free PMC article.
-
The chemical ecology of cyanobacteria.Nat Prod Rep. 2012 Mar;29(3):372-91. doi: 10.1039/c2np00075j. Epub 2012 Jan 12. Nat Prod Rep. 2012. PMID: 22237837 Free PMC article. Review.
References
-
- Mundt S, Kreitlow S, Nowotny A, Effmert U. Int. J. Hyg. Envir. Heal. 2001;203:327–334. - PubMed
-
- Kreitlow S, Mundt S, Lindequist U. J. Biotechnol. 1999;70:61–63. - PubMed
-
- Muller D, Krick A, Kehraus S, Mehner C, Hart M, Kupper FC, Saxena K, Prinz H, Schwalbe H, Janning P, Waldmann H, Konig GM. J. Med. Chem. 2006;49:4871–4878. - PubMed
-
- Luesch H, Pangilinan R, Yoshida WY, Moore RE, Paul VJ. J. Nat. Prod. 2001;64:304–307. - PubMed
-
- Singh S, Kate BN, Banerjee UC. Crit. Rev. Biotechnol. 2005;25:73–95. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials